Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials. [electronic resource]
Producer: 20170403Description: 453-9 p. digitalISSN:- 2296-5262
- Antineoplastic Agents -- administration & dosage
- Bone Density Conservation Agents -- administration & dosage
- Bone Neoplasms -- drug therapy
- Cancer Pain -- epidemiology
- Causality
- Comorbidity
- Denosumab -- administration & dosage
- Diphosphonates -- administration & dosage
- Drug-Related Side Effects and Adverse Reactions -- epidemiology
- Evidence-Based Medicine
- Female
- Humans
- Imidazoles -- administration & dosage
- Male
- Patient Safety
- Prevalence
- Randomized Controlled Trials as Topic -- statistics & numerical data
- Risk Factors
- Treatment Outcome
- Zoledronic Acid
No physical items for this record
Publication Type: Comparative Study; Journal Article; Meta-Analysis; Review
There are no comments on this title.
Log in to your account to post a comment.